AG NPP709 is currently available on the market; however, no examine has investigated the result of AG NPP709 in clients with COPD. Therefore, the aim of this analyze was to evaluate the efficacy of AG NPP709 in individuals with chronic bronchitis type COPD.Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-